A new antibiotic that targets only a specific strain of bacteria, while sparing friendlier bacteria, might one day bring some respite to patients with inflammatory bowel diseases (IBD). The development of this antibiotic is part of the first…
AI-designed antibiotic targets harmful gut bacteria while sparing beneficial microbes
